Stockscreener 앱 받기
7.85
3.63%
-0.28
전일 마감가:
$8.13
열려 있는:
$8.1872
하루 거래량:
4,035
Relative Volume:
0.06
시가총액:
$58.55M
수익:
$71,000
순이익/손실:
$-2.47M
주가수익비율:
-0.2385
EPS:
-32.9143
순현금흐름:
$-5.24M
1주 성능:
-12.17%
1개월 성능:
-21.97%
6개월 성능:
-16.96%
1년 성능:
-66.06%
1일 변동 폭
$8.005
$8.20
1주일 범위
$8.005
$8.70
52주 변동 폭
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
명칭
Pavmed Inc
전화
(212) 949-4319
주소
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
8.05 | 58.55M | 71,000 | -2.47M | -5.24M | -32.91 |
ABT
Abbott Laboratories
|
87.02 | 151.83B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.16 | 113.08B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
78.00 | 99.87B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.33 | 83.21B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.44 | 47.80B | 6.30B | 1.07B | 1.34B | 1.8406 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 개시 | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 개시 | Maxim Group | Buy |
Pavmed Inc 주식(PAVM)의 최신 뉴스
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Q3 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
Q1 2025 PAVmed Inc Earnings Call Transcript - GuruFocus
PAVmed Inc (FRA:1P5) Stock Earnings Transcripts - GuruFocus
PAVmed Inc (FRA:1P5) Stock Price & 30 Year Financial Data - GuruFocus
PAVmed Inc (FRA:1P5) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
PAVmed (PAVM) 2026 proxy: ESPP share increase, director elections and auditor vote - Stock Titan
PAVmed will outline Q1 results and strategy in a May 15 webcast - Stock Titan
[ARS] PAVmed Inc. SEC Filing - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) seeks big share increase in 2026 proxy - Stock Titan
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 - BioSpace
Lucid Diagnostics to Hold First Quarter 2026 Business Update Con - GuruFocus
Lucid Diagnostics will detail Q1 results and strategy on May 14 - Stock Titan
[EFFECT] PAVmed Inc. SEC Filing - Stock Titan
SEC Form DEFA14A filed by PAVmed Inc. - Quantisnow
PAVmed Inc. (NASDAQ: PAVM) registers 9.23M shares from Series D conversion - Stock Titan
PAVM Technical Analysis | Trend, Signals & Chart Patterns | PAVMED INC (NASDAQ:PAVM) - ChartMill
PAVmed (PAVM) price target decreased by 84.60% to 41.31 - MSN
PAVmed Inc (STU:1P5) Stock PDF (Updated: 2026/04/28) - GuruFocus
Debt to equity ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Pretax income of PAVmed, Inc. – FWB:1P5 - TradingView
Free cash flow of PAVmed, Inc. – FWB:1P5 - TradingView
Return on invested capital % of PAVmed, Inc. – FWB:1P5 - TradingView
Taxes of PAVmed, Inc. – FWB:1P5 - TradingView
Debt to assets ratio of PAVmed, Inc. – FWB:1P5 - TradingView
Total equity of PAVmed, Inc. – FWB:1P5 - TradingView
PAVmed (PAVM) upgraded to buy: Here's what you should know - MSN
PAVmed Q2 2025 Earnings Preview - MSN
Why The PAVmed (PAVM) Story Is Shifting After A Major Valuation Reset - Yahoo Finance
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock - marketscreener.com
PAVmed (PAVM) price target increased by 2,900.00% to 321.30 - MSN
Lucid Diagnostics Raises Capital Through Direct Share Offering - The Globe and Mail
Lucid Diagnostics closes $18M stock offering at $1 per share - Investing.com Australia
Latest PAVM NewsPAVmed Collaborates with Canon on DisappEAR... - Stock Titan
Lucid Diagnostics (NASDAQ: LUCD) closes $18M underwritten stock sale - Stock Titan
Lucid Diagnostics closes $18M stock offering at $1 per share By Investing.com - Investing.com India
Lucid Diagnostics prices $18M stock offering at $1 per share - Investing.com India
Backed by a $15M investor, Lucid closes $18M share sale - Stock Titan
Lucid Diagnostics Prices $18 Million Public Equity Offering - TipRanks
Lucid Diagnostics (Nasdaq: LUCD) prices $18M underwritten stock sale - Stock Titan
Lucid Diagnostics prices $18M stock offering at $1 per share By Investing.com - Investing.com South Africa
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock - Financial Times
A $15M anchor investor backs Lucid’s 18M-share stock sale - Stock Titan
PAVmed Inc. (PAVM) posts narrow Q4 2025 EPS miss, shares edge higher in muted investor trading.Community Exit Signals - Cổng thông tin điện tử tỉnh Tây Ninh
PAVmed (NASDAQ: PAVM) registers 9.23M common shares; $30M potential from warrants - Stock Titan
PAVmed IncFiles Prospectus For Potential Offer And Sale Of 9.23 Million Common Shares By Selling StockholdersSEC Filing - TradingView
Lucid Diagnostics (NASDAQ: LUCD) seeks 100M-share authorization increase - Stock Titan
PAVmed Inc. Series Z Warrant (PAVMZ) - Minichart
PAVmed (PAVM) Stock Resistance Rejection (+0.11%) 2026-04-18Sentiment Analysis - Xã Vĩnh Công
Pavmed Inc (PAVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.76%
0.72%
자본화:
|
볼륨(24시간):